Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Secondary malignant neoplasm of liver
0.030 Biomarker disease BEFREE Baseline 3D-ADC outperforms 2D-ADC in predicting response to treatment in patients with colorectal liver metastases. 31209620 2020
Secondary malignant neoplasm of liver
0.030 Biomarker disease BEFREE Considering tumour volume for motion corrected DWI of colorectal liver metastases increases sensitivity of ADC to detect treatment-induced changes. 30846790 2019
Secondary malignant neoplasm of liver
0.030 Biomarker disease BEFREE Whole-tumour histogram analysis of ADC maps may be helpful in predicting tumour grade, vascular involvement, nodal and liver metastases in panNENs. 29352378 2018